Concerning developments reported last year suggest that gonorrhea may be beginning to outsmart our last recommended treatment. Keeping an eye on antibiotic resistance has never been more important. CDC has developed these new tools to assist in your efforts to make sure your communities are aware of the emerging threat of drug-resistant gonorrhea and to help them better understand the issue:
- A NEW video animation was developed to help raise awareness about drug-resistant gonorrhea. It illustrates gonorrhea’s history of overpowering almost every drug ever used to treat it, the current battles we face as the bacterium evolve, and the dangers of this common infection becoming untreatable. Please share with your memberships and those who seek to educate community leaders and others about this topic.
- The 2015 Gonococcal Isolate Surveillance Project (GISP) Profiles are also now available. In addition to the national antimicrobial susceptibility results included in the 2015 STD Surveillance Report, the GISP Profiles provide a one-stop resource to assure you have the most up-to-date national andlocal CDC antimicrobial susceptibility data. For more than 30 years, these data have helped those of us in public health ensure gonorrhea is successfully treated with the right drugs.
Thank you for your continued commitment to prevention and your efforts to keep drug-resistant gonorrhea a top public health priority.
Sincerely,
Gail Bolan, M.D. Director,Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control and Prevention
.png)
No hay comentarios:
Publicar un comentario